C-Care and Healthcare Global Enterprises join forces in the fight against cancer

C-Care (Mauritius), the leading private healthcare provider in Mauritius, and Healthcare Global Enterprises (HCG), the leader in India in speciality healthcare services focused on oncology, have entered into a strategic partnership, effective from July 1, 2024. This collaboration marks an important milestone in the local healthcare sector. Under the terms of the Memorandum of Understanding (MoU), HCG will offer clinical and outpatient consultation (OPD) services at the C-Care Cancer Center, located within C-Care Darné, in Floréal. These services will be facilitated by HCG doctors specialising in specific areas of oncology.

The partnership focuses on five key areas: cutting-edge clinical services, training and knowledge-sharing, advanced diagnostic services, facilitation of patient referrals, and an unwavering commitment to excellence. HCG will provide oncologists specialising in specific and complex cases of cancer to Mauritian patients, ensuring access to the most advanced care. Patients will benefit from personalised treatments, coupled with international expertise. 

According tot the statement released, C-Care’s nuclear medicine staff will receive training from HCG experts to enhance their skills and knowledge, supporting the professional development of the Mauritian teams and improving patient care. Nuclear medicine is a medical specialty that uses the properties of radioactivity for medical purposes.

C-Care patients can be referred to HCG for PET scans, including both conventional and digital PET scans, at preferential rates. The agreement also guarantees patient follow-up and continuity of care. Mauritians requiring advanced cancer treatments that are not available locally will be referred to HCG hospitals in India, ensuring access to comprehensive care options.

Raj Gore, CEO, Healthcare Global Enterprises added, “This MoU represents a shared vision of improving cancer care and making it more accessible to patients in the region. By bringing our expertise through our cutting-edge clinical and OPD services, we are committed to provide personalised, advanced and precise cancer care to the citizens of Mauritius. This collaboration will not only significantly enhance the quality of care available but also provide opportunities for C-Care’s medical team to expand their expertise through collaborative training and knowledge exchange.”

 Hélène Echevin, CEO of C-Care Group, said, “This collaboration with HCG underlines our commitment to providing world-class healthcare to our patients. By leveraging HCG’s expertise, we aim to improve the quality of cancer care available in Mauritius and ensure that our patients have access to the best possible treatment options. This collaboration will also enable our teams to achieve a high level of quality in all aspects of cancer, even the most complex.”

The partnership between C-Care and HCG demonstrates both organisations’ dedication to advancing healthcare and providing patients with the highest standards of medical care. With C-Care having obtained all necessary government approvals, both organisations are committed to ensuring the seamless delivery of HCG’s services and maintaining the highest standards of medical care.